Titre : Acides lévuliniques

Acides lévuliniques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Methicillin-Resistant Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acides lévuliniques : Questions médicales les plus fréquentes", "headline": "Acides lévuliniques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acides lévuliniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-05-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acides lévuliniques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cétoacides", "url": "https://questionsmedicales.fr/mesh/D007651", "about": { "@type": "MedicalCondition", "name": "Cétoacides", "code": { "@type": "MedicalCode", "code": "D007651", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.755" } } }, "about": { "@type": "MedicalCondition", "name": "Acides lévuliniques", "alternateName": "Levulinic Acids", "code": { "@type": "MedicalCode", "code": "D007982", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kyoungseon Min", "url": "https://questionsmedicales.fr/author/Kyoungseon%20Min", "affiliation": { "@type": "Organization", "name": "Gwangju Clean Energy Research Center, Korea Institute of Energy Research (KIER), Gwangju 61003, Republic of Korea. Electronic address: min4605@kier.re.kr." } }, { "@type": "Person", "name": "Zhihao Yu", "url": "https://questionsmedicales.fr/author/Zhihao%20Yu", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } }, { "@type": "Person", "name": "Xuebin Lu", "url": "https://questionsmedicales.fr/author/Xuebin%20Lu", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } }, { "@type": "Person", "name": "Jian Xiong", "url": "https://questionsmedicales.fr/author/Jian%20Xiong", "affiliation": { "@type": "Organization", "name": "Department of Chemistry & Environmental Science, School of Science, Tibet University, Lhasa, 850000, P. R. China." } }, { "@type": "Person", "name": "Na Ji", "url": "https://questionsmedicales.fr/author/Na%20Ji", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Nonclassical Mechanism of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus and Its Effect on Virulence.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36314912", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/spectrum.02284-22" } }, { "@type": "ScholarlyArticle", "name": "Distribution of MecA and Erm Genes among Methicillin-resistant Staphylococcus Aureus with Inducible Resistance to Clindamycin.", "datePublished": "2023-09-08", "url": "https://questionsmedicales.fr/article/37742145", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.33314/jnhrc.v21i1.4337" } }, { "@type": "ScholarlyArticle", "name": "High Prevalence of Multi-drug Resistant Methicillin-Resistant Staphylococcus aureus in Tertiary Egyptian Hospitals.", "datePublished": "2022-05-30", "url": "https://questionsmedicales.fr/article/35656950", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3855/jidc.15833" } }, { "@type": "ScholarlyArticle", "name": "Dissemination of Methicillin-Resistant Staphylococcus aureus Sequence Type 764 Isolates with Mupirocin Resistance in China.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36622214", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/spectrum.03794-22" } }, { "@type": "ScholarlyArticle", "name": "Purulent lymphadenitis caused by ST59 community-associated Methicillin-resistant Staphylococcus aureus in an infant.", "datePublished": "2024-05-30", "url": "https://questionsmedicales.fr/article/38865394", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3855/jidc.18798" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Cétoacides", "item": "https://questionsmedicales.fr/mesh/D007651" }, { "@type": "ListItem", "position": 5, "name": "Acides lévuliniques", "item": "https://questionsmedicales.fr/mesh/D007982" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acides lévuliniques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acides lévuliniques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acides lévuliniques", "description": "Comment diagnostiquer une intoxication aux acides lévuliniques ?\nQuels tests sont utilisés pour détecter les acides lévuliniques ?\nQuels symptômes indiquent une exposition aux acides lévuliniques ?\nY a-t-il des marqueurs biologiques pour les acides lévuliniques ?\nLes tests d'imagerie sont-ils utiles pour les acides lévuliniques ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acides lévuliniques", "description": "Quels sont les symptômes courants d'une exposition ?\nLes acides lévuliniques provoquent-ils des allergies ?\nY a-t-il des effets à long terme d'une exposition ?\nLes symptômes varient-ils selon la dose ?\nLes enfants sont-ils plus sensibles aux acides lévuliniques ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acides lévuliniques", "description": "Comment prévenir l'exposition aux acides lévuliniques ?\nLes travailleurs doivent-ils être formés ?\nDes équipements de protection sont-ils nécessaires ?\nY a-t-il des réglementations sur leur utilisation ?\nLes fuites doivent-elles être signalées ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acides lévuliniques", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les acides lévuliniques ?\nComment traiter les irritations cutanées causées ?\nLes soins d'urgence sont-ils nécessaires ?\nLa détoxification est-elle recommandée ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acides lévuliniques", "description": "Quelles complications peuvent survenir après exposition ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de cancer liés aux acides lévuliniques ?\nLes complications peuvent-elles affecter la santé mentale ?\nDes soins de suivi sont-ils nécessaires après exposition ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acides lévuliniques", "description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il la sensibilité ?\nLes personnes allergiques sont-elles plus à risque ?\nY a-t-il des prédispositions génétiques ?\nLes conditions de santé préexistantes augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux acides lévuliniques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les acides lévuliniques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux d'acides." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux acides lévuliniques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des nausées, des vertiges et des douleurs abdominales peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les acides lévuliniques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de marqueurs biologiques spécifiques pour ces acides." } }, { "@type": "Question", "name": "Les tests d'imagerie sont-ils utiles pour les acides lévuliniques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'imagerie ne sont généralement pas utilisés pour diagnostiquer l'exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées." } }, { "@type": "Question", "name": "Les acides lévuliniques provoquent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques à ces acides." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme d'une exposition ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des problèmes respiratoires et cutanés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Les enfants sont-ils plus sensibles aux acides lévuliniques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques de ces acides." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux acides lévuliniques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des acides lévuliniques et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle pour les travailleurs." } }, { "@type": "Question", "name": "Des équipements de protection sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des gants et des masques doivent être portés lors de la manipulation de ces acides." } }, { "@type": "Question", "name": "Y a-t-il des réglementations sur leur utilisation ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent l'utilisation des acides lévuliniques dans l'industrie." } }, { "@type": "Question", "name": "Les fuites doivent-elles être signalées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, toute fuite ou déversement doit être signalé immédiatement aux autorités compétentes." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement à éliminer l'exposition et à gérer les symptômes." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les acides lévuliniques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour l'intoxication aux acides lévuliniques." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des soins d'urgence peuvent être nécessaires en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "La détoxification est-elle recommandée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La détoxification n'est généralement pas nécessaire, mais une surveillance médicale est conseillée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles respiratoires ou des dermatites peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des complications sont réversibles avec un traitement approprié et rapide." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés aux acides lévuliniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de preuves concluantes liant ces acides à un risque accru de cancer." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la santé mentale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications physiques peuvent entraîner des effets sur la santé mentale, comme l'anxiété." } }, { "@type": "Question", "name": "Des soins de suivi sont-ils nécessaires après exposition ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical est recommandé pour surveiller d'éventuelles complications tardives." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique sont les plus à risque d'exposition aux acides." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "Les personnes allergiques sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus sensibles aux acides." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines prédispositions génétiques peuvent influencer la sensibilité aux toxines." } }, { "@type": "Question", "name": "Les conditions de santé préexistantes augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme l'asthme ou des maladies cutanées peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Distribution of MecA and Erm Genes among Methicillin-resistant Staphylococcus Aureus with Inducible Resistance to Clindamycin.

The emergence of Methicillin-resistant Staphylococcus aureus and its ability to confer cross-resistance to macrolide-lincosamide-streptogramin B has complicated the treatment against it. Gene-based st... S. aureus isolated from different clinical samples was identified by standard microbiological procedures (Gram-staining, colony morphology, and different biochemical tests). Methicillin-resistant and ... Among 120 S. aureus isolates, 51.67% (n=62) were MRSA, and the prevalence of inducibly-resistant, constitutively-resistant and Macrolide-Streptogramin phenotypes were 15.83% (n=19), 28.33% (n=34) and ... Macrolides-Lincosamide-Streptogramin B resistance was predominant among methicillin-resistant S. aureus. While all isolates with inducible clindamycin resistance harbored mecA gene, most of them also ...

High Prevalence of Multi-drug Resistant Methicillin-Resistant Staphylococcus aureus in Tertiary Egyptian Hospitals.

Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of morbidity and mortality worldwide. This work aimed to study the occurrence of multidrug-resistant MRSA (MDR-MRSA) in tertiary... A total of 170 S. aureus isolates were collected from two Egyptian tertiary hospitals in Cairo, between September 2017 and December 2018. MRSA isolates were identified using the conventional microbiol... High prevalence of MRSA isolates was identified (138/170, 81.2%) with 79% of isolates (109/138, 79%) being MDR-MRSA. MRSA isolates were resistant to diverse classes of antimicrobials including β-lacta... MRSA infections remain a noteworthy problem in Egyptian hospitals. MDR-MRSA isolates showed significant genetic diversity indicating the alarmingly high prevalence. Studies should be performed frequen...

Dissemination of Methicillin-Resistant Staphylococcus aureus Sequence Type 764 Isolates with Mupirocin Resistance in China.

Mupirocin, a topical antimicrobial agent, is an important component in the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization. The molecular characteristics of 46 mupirocin...

Purulent lymphadenitis caused by ST59 community-associated Methicillin-resistant Staphylococcus aureus in an infant.

Methicillin-resistant Staphylococcus aureus (CA-MRSA), which has the potential to produce serious infections, was a common cause of skin and soft tissue infections, acute purulent lymphadenitis was ra... The patient was a female infant with lumps, tenderness, and fever on the right side of the neck and groin. Laboratory tests suggested a bacterial infection. The diagnosis of acute purulent lymphadenit... 17 days after admission, the patient showed signs of clinical recovery.... The incident brought to light the possible spread of CA-MRSA in the Chinese population. Even without a definite path of infection, CA-MRSA should be taken into consideration when the standard treatmen...

Effects of Phomopsidione on the Viability, Virulence, and Metabolites Profile of Methicillin-Resistant Staphylococcus aureus (MRSA).

Methicillin-resistant Staphylococcus aureus (MRSA) infections have become one of the most threatening multidrug-resistant pathogens. Thus, an ongoing search for anti-MRSA compounds remains an urgent n...

Antibacterial and antibiofilm efficacy of repurposing drug hexestrol against methicillin-resistant Staphylococcus aureus.

There has been an explosion in the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) because of the indiscriminate use of antibiotics. In this study, we repurposed hexestrol (HXS) as an...

Rapid identification of methicillin-resistant Staphylococcus aureus by MALDI-TOF MS: A meta-analysis.

Invasive infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are associated with high mortality and morbidity. The sooner the pathogen is determined, the better it is beneficial to...

Sub-inhibitory concentrations of tetrabromobisphenol A induce the biofilm formation of methicillin-resistant Staphylococcus aureus.

Biofilm formation by methicillin-resistant Staphylococcus aureus (MRSA) on indwelling medical devices complicates the treatment of infection. Tetrabromobisphenol A (TBBPA), a synthetic, lipophilic, ha...

Increased Incidence of Methicillin-Resistant Staphylococcus aureus in Knee and Hip Prosthetic Joint Infection.

Periprosthetic joint infection (PJI) is a devastating complication of knee and hip arthroplasty. Past literature has shown that gram-positive bacteria are commonly responsible for these infections, al... This is a multi-institutional retrospective review of patients who had a knee or hip PJI from 1990 to 2020. Patients with a known causative organism were included and those with insufficient culture s... There was a statistically significant positive linear trend in the incidence of methicillin-resistant Staphylococcus aureus over time (P = .0088) as well as a statistically significant negative linear... The incidence of methicillin-resistant Staphylococcus aureus PJI is increasing over time, whereas, coagulase-negative staphylococci PJI is decreasing, paralleling the global trend of antibiotic resist...